{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:02:31Z","timestamp":1791468151712,"version":"4.3.4"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.intimp.2026.117494","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T03:14:53Z","timestamp":1790565293000},"page":"117494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["From orphan receptor to versatile regulator: Redefining LILRB3 as a context-dependent immune checkpoint and therapeutic target"],"prefix":"10.1016","volume":"190","author":[{"given":"Xinyu","family":"Zong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xionghan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijun","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2026.117494_bb0005","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211463","article-title":"Inhibitory pattern recognition receptors","volume":"219","author":"Rumpret","year":"2022","journal-title":"J. Exp. Med."},{"issue":"18","key":"10.1016\/j.intimp.2026.117494_bb0010","doi-asserted-by":"crossref","first-page":"9463","DOI":"10.1128\/JVI.01009-10","article-title":"Leukocyte immunoglobulin-like receptors maintain unique antigen-presenting properties of circulating myeloid dendritic cells in HIV-1-infected elite controllers","volume":"84","author":"Huang","year":"2010","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117494_bb0015","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41422-022-00759-y","article-title":"LilrB3 is a putative cell surface receptor of APOE4","volume":"33","author":"Zhou","year":"2023","journal-title":"Cell Res."},{"issue":"11","key":"10.1016\/j.intimp.2026.117494_bb0020","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/s43018-021-00262-0","article-title":"LILRB3 supports acute myeloid leukemia development and regulates T-cell antitumor immune responses through the TRAF2-cFLIP-NF-\u03baB signaling axis","volume":"2","author":"Wu","year":"2021","journal-title":"Nat. Cancer"},{"issue":"5","key":"10.1016\/j.intimp.2026.117494_bb0025","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1038\/s41591-025-03568-z","article-title":"LILRB3 genetic variation is associated with kidney transplant failure in African American recipients","volume":"31","author":"Sun","year":"2025","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.intimp.2026.117494_bb0030","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00629-24","article-title":"Sialic acid and PirB are not required for targeting of neural circuits by neurotropic mammalian orthoreovirus","volume":"9","author":"Griswold","year":"2024","journal-title":"mSphere"},{"issue":"1","key":"10.1016\/j.intimp.2026.117494_bb0035","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1038\/s41467-023-38327-6","article-title":"Paired immunoglobulin-like receptor B is an entry receptor for mammalian orthoreovirus","volume":"14","author":"Shang","year":"2023","journal-title":"Nat. Commun."},{"issue":"6152","key":"10.1016\/j.intimp.2026.117494_bb0040","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1126\/science.1242077","article-title":"Human LilrB2 is a \u03b2-amyloid receptor and its murine homolog PirB regulates synaptic plasticity in an Alzheimer\u2019s model","volume":"341","author":"Kim","year":"2013","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.intimp.2026.117494_bb0045","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.4049\/jimmunol.1701450","article-title":"Glatiramer acetate enhances myeloid-derived suppressor cell function via recognition of paired Ig-like receptor B","volume":"201","author":"van der Touw","year":"2018","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117494_bb0050","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.jcmgh.2021.06.013","article-title":"PIR-B regulates CD4(+) IL17a(+) T-cell survival and restricts T-cell-dependent intestinal inflammatory responses","volume":"12","author":"Uddin","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"18","key":"10.1016\/j.intimp.2026.117494_bb0055","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.141593","article-title":"LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation","volume":"5","author":"Yeboah","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.intimp.2026.117494_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2024.12995","article-title":"The potential role of the leucocyte immunoglobulin-like receptors in kidney transplant rejection: a mini review","volume":"37","author":"Palvair","year":"2024","journal-title":"Transpl. Int."},{"issue":"4","key":"10.1016\/j.intimp.2026.117494_bb0065","doi-asserted-by":"crossref","first-page":"954","DOI":"10.4049\/jimmunol.1900852","article-title":"The orphan immune receptor LILRB3 modulates Fc receptor-mediated functions of neutrophils","volume":"204","author":"Zhao","year":"2020","journal-title":"J. Immunol."},{"issue":"13","key":"10.1016\/j.intimp.2026.117494_bb0070","doi-asserted-by":"crossref","first-page":"15618","DOI":"10.18632\/oncotarget.6905","article-title":"Allele-specific recognition by LILRB3 and LILRA6 of a cytokeratin 8-associated ligand on necrotic glandular epithelial cells","volume":"7","author":"Jones","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.intimp.2026.117494_bb0075","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00251-022-01286-1","article-title":"Distinct frequency patterns of LILRB3 and LILRA6 allelic variants in Europeans","volume":"75","author":"Bashirova","year":"2023","journal-title":"Immunogenetics"},{"issue":"7","key":"10.1016\/j.intimp.2026.117494_bb0080","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s10038-021-00906-0","article-title":"Characterization of LILRB3 and LILRA6 allelic variants in the Japanese population","volume":"66","author":"Hirayasu","year":"2021","journal-title":"J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.intimp.2026.117494_bb0085","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00251-013-0742-5","article-title":"Copy number and nucleotide variation of the LILR family of myelomonocytic cell activating and inhibitory receptors","volume":"66","author":"L\u00f3pez-\u00c1lvarez","year":"2014","journal-title":"Immunogenetics"},{"issue":"1","key":"10.1016\/j.intimp.2026.117494_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00251-013-0730-9","article-title":"Diversity of the human LILRB3\/A6 locus encoding a myeloid inhibitory and activating receptor pair","volume":"66","author":"Bashirova","year":"2014","journal-title":"Immunogenetics"},{"issue":"6199","key":"10.1016\/j.intimp.2026.117494_bb0095","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1126\/science.1256271","article-title":"Immunogenetics. Chromatin state dynamics during blood formation","volume":"345","author":"Lara-Astiaso","year":"2014","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.intimp.2026.117494_bb0100","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nri3777","article-title":"Epigenetic control of myeloid cell differentiation, identity and function","volume":"15","author":"\u00c1lvarez-Errico","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"24","key":"10.1016\/j.intimp.2026.117494_bb0105","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1158\/0008-5472.CAN-22-2483","article-title":"LILRB3 modulates acute myeloid leukemia progression and acts as an effective target for CAR T-cell therapy","volume":"83","author":"Mai","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2026.117494_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1293828","article-title":"Soluble CD83 modulates human-monocyte-derived macrophages toward alternative phenotype, function, and metabolism","volume":"14","author":"Peckert-Maier","year":"2023","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2026.117494_bb0115","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1002\/eji.200324732","article-title":"A gene signature of inhibitory MHC receptors identifies a BDCA3(+) subset of IL-10-induced dendritic cells with reduced allostimulatory capacity in vitro","volume":"34","author":"Velten","year":"2004","journal-title":"Eur. J. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2026.117494_bb0120","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1093\/infdis\/jiz319","article-title":"Immunoglobulin-like transcript 5 inhibits macrophage-mediated bacterial killing and antigen presentation during sepsis","volume":"220","author":"Ming","year":"2019","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.intimp.2026.117494_bb0125","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.4049\/jimmunol.1003078","article-title":"HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding","volume":"186","author":"Jones","year":"2011","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2026.117494_bb0130","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.4049\/jimmunol.167.10.5543","article-title":"Leukocyte receptor complex-encoded immunomodulatory receptors show differing specificity for alternative HLA-B27 structures","volume":"167","author":"Allen","year":"2001","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2026.117494_bb0135","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/ni961","article-title":"Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor","volume":"4","author":"Willcox","year":"2003","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2026.117494_bb0140","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/s41590-021-01045-6","article-title":"Epithelial cells remove precancerous cells by cell competition via MHC class I-LILRB3 interaction","volume":"22","author":"Ayukawa","year":"2021","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117494_bb0145","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1158\/2326-6066.CIR-23-0496","article-title":"LILRB3 supports immunosuppressive activity of myeloid cells and tumor development","volume":"12","author":"Huang","year":"2024","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.intimp.2026.117494_bb0150","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.freeradbiomed.2024.05.047","article-title":"Cannabidiol mitigates radiation-induced intestine ferroptosis via facilitating the heterodimerization of RUNX3 with CBF\u03b2 thereby promoting transactivation of GPX4","volume":"222","author":"Huang","year":"2024","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.intimp.2026.117494_bb0155","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.immuni.2011.02.004","article-title":"Paired immunoglobin-like receptor-B regulates the suppressive function and fate of myeloid-derived suppressor cells","volume":"34","author":"Ma","year":"2011","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.intimp.2026.117494_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1396","article-title":"LILRB3 suppresses immunity in glioma and is associated with poor prognosis","volume":"13","author":"Zhuang","year":"2023","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.117494_bb0165","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s40364-024-00705-7","article-title":"The LILRB family in hematologic malignancies: prognostic associations, mechanistic considerations, and therapeutic implications","volume":"12","author":"Hodges","year":"2024","journal-title":"Biomark. Res."},{"issue":"7","key":"10.1016\/j.intimp.2026.117494_bb0170","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.4049\/jimmunol.181.7.4742","article-title":"Inhibitory immunoglobulin-like receptors LILRB and PIR-B negatively regulate osteoclast development","volume":"181","author":"Mori","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2026.117494_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00857","article-title":"Leukocyte immunoglobulin-like receptors (LILRs) on human neutrophils: modulators of infection and immunity","volume":"11","author":"Lewis Marffy","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117494_bb0180","doi-asserted-by":"crossref","DOI":"10.1177\/20406207241257904","article-title":"Integrated genetic, epigenetic, and immune landscape of TP53 mutant AML and higher risk MDS treated with azacitidine","volume":"15","author":"Zeidan","year":"2024","journal-title":"Ther. Adv. Hematol."},{"key":"10.1016\/j.intimp.2026.117494_bb0185","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1600-065X.2008.00653.x","article-title":"The extended human leukocyte receptor complex: diverse ways of modulating immune responses","volume":"224","author":"Barrow","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2026.117494_bb0190","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s41232-020-00119-6","article-title":"Roles of cytotoxic lymphocytes and MIC\/LILR families in pathophysiology of Takayasu arteritis","volume":"40","author":"Yoshifuji","year":"2020","journal-title":"Inflamm. Regen."},{"issue":"2","key":"10.1016\/j.intimp.2026.117494_bb0195","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s13353-024-00878-9","article-title":"Bioinformatics screening of prognostic immune-related genes in renal clear cell carcinoma","volume":"66","author":"Cui","year":"2025","journal-title":"J. Appl. Genet."},{"issue":"5","key":"10.1016\/j.intimp.2026.117494_bb0200","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41581-025-00959-w","article-title":"Association of LILRB3 variants with kidney transplant failure in African Americans","volume":"21","author":"Allison","year":"2025","journal-title":"Nat. Rev. Nephrol."},{"issue":"9","key":"10.1016\/j.intimp.2026.117494_bb0205","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1007\/s12031-022-02043-5","article-title":"Diagnosis and drug prediction of Parkinson's disease based on immune-related genes","volume":"72","author":"Bao","year":"2022","journal-title":"J. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.intimp.2026.117494_bb0210","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2025.2546684","article-title":"Comprehensive analysis of the leukocyte immunoglobulin-like receptor family in clear cell renal cell carcinoma","volume":"57","author":"He","year":"2025","journal-title":"Ann. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.117494_bb0215","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s12967-024-05070-5","article-title":"CLPs-miR-103a-2-5p inhibits proliferation and promotes cell apoptosis in AML cells by targeting LILRB3 and Nrf2\/HO-1 axis, regulating CD8+T cell response","volume":"22","author":"Cen","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.intimp.2026.117494_bb0220","doi-asserted-by":"crossref","unstructured":"Abbasi AB, Sarwal MM. Leukocyte immunoglobulin like receptor B3 (LILRB3) and allograft survival: can precision medicine target health disparities? Kidney Int. 2025 Dec;108(6):982-984. doi: 10.1016\/j.kint.2025.06.020. Epub 2025 Aug 25. PMID: 40856677.","DOI":"10.1016\/j.kint.2025.06.020"},{"issue":"8","key":"10.1016\/j.intimp.2026.117494_bb0225","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jmoldx.2025.05.002","article-title":"Comparison of the mutational profile between BCL2- and BCL6-rearrangement positive follicular lymphoma","volume":"27","author":"Ikoma","year":"2025","journal-title":"J. Mol. Diagn."},{"issue":"7400","key":"10.1016\/j.intimp.2026.117494_bb0230","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nature11095","article-title":"Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development","volume":"485","author":"Zheng","year":"2012","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.intimp.2026.117494_bb0235","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00262-017-2023-x","article-title":"LILRB receptor-mediated regulation of myeloid cell maturation and function","volume":"66","author":"van der Touw","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"issue":"5","key":"10.1016\/j.intimp.2026.117494_bb0240","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1158\/2326-6066.CIR-23-0568","article-title":"ILT2 and ILT4 drive myeloid suppression via both overlapping and distinct mechanisms","volume":"12","author":"Tian","year":"2024","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.intimp.2026.117494_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1240275","article-title":"Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer","volume":"14","author":"Zeller","year":"2023","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117494_bb0250","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3892\/ol.2025.14927","article-title":"Targeting leukocyte immunoglobulin-like receptor B2 in the tumor microenvironment: a new treatment prospect for solid tumors (review)","volume":"29","author":"Cao","year":"2025","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.intimp.2026.117494_bb0255","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/s41467-018-03128-9","article-title":"Human Semaphorin-4A drives Th2 responses by binding to receptor ILT-4","volume":"9","author":"Lu","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2026.117494_bb0260","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41392-025-02462-x","article-title":"Oligomeric cystatin C supports the immunosuppressive activity of myeloid cells through interaction with inhibitory receptors","volume":"10","author":"Zhang","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"118","key":"10.1016\/j.intimp.2026.117494_bb0265","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adt7832","article-title":"Claudins interact with LILRB immune inhibitory receptors to promote myeloid immunosuppression in cancer","volume":"11","author":"Liu","year":"2026","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.intimp.2026.117494_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116762","article-title":"LILRB4 as a novel immunotherapeutic target for multiple diseases","volume":"233","author":"Wang","year":"2025","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.intimp.2026.117494_bb0275","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/intimm\/dxab028","article-title":"Blockade of checkpoint ILT3\/LILRB4\/gp49B binding to fibronectin ameliorates autoimmune disease in BXSB\/Yaa mice","volume":"33","author":"Su","year":"2021","journal-title":"Int. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2026.117494_bb0280","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1158\/2326-6066.CIR-21-0240","article-title":"The fibronectin-ILT3 interaction functions as a stromal checkpoint that suppresses myeloid cells","volume":"9","author":"Paavola","year":"2021","journal-title":"Cancer Immunol. Res."},{"issue":"8","key":"10.1016\/j.intimp.2026.117494_bb0285","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/intimm\/dxac023","article-title":"Myeloid immune checkpoint ILT3\/LILRB4\/gp49B can co-tether fibronectin with integrin on macrophages","volume":"34","author":"Itoi","year":"2022","journal-title":"Int. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2026.117494_bb0290","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/s41590-025-02233-4","article-title":"Secretogranin 2 binds LILRB4 resulting in immunosuppression","volume":"26","author":"Yang","year":"2025","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2026.117494_bb0295","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1158\/2326-6066.CIR-24-0737","article-title":"Eph receptors activate myeloid checkpoint receptor LILRB5 to support tumor development","volume":"13","author":"He","year":"2025","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.intimp.2026.117494_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1398935","article-title":"Identification of the hybrid gene LILRB5-3 by long-read sequencing and implication of its novel signaling function","volume":"15","author":"Hirayasu","year":"2024","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2026.117494_bb0305","doi-asserted-by":"crossref","first-page":"641","DOI":"10.5582\/bst.2025.01148","article-title":"APOE4 reprograms microglial lipid metabolism in Alzheimer\u2019s disease: Mechanisms and therapeutic implications","volume":"19","author":"Chen","year":"2026","journal-title":"Biosci Trends"},{"key":"10.1016\/j.intimp.2026.117494_bb0310","article-title":"Intracranial aneurysms induced by RUNX1 through regulation of NFKB1 in patients with hypertension-an integrated analysis based on multiple datasets and algorithms","volume":"13","author":"Li","year":"2022","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117494_bb0315","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3390\/hematolrep15010020","article-title":"Mutational profile and pathological features of a case of interleukin-10 and RGS1-positive spindle cell variant diffuse large B-cell lymphoma","volume":"15","author":"Carreras","year":"2023","journal-title":"Hematol. Rep."},{"issue":"2","key":"10.1016\/j.intimp.2026.117494_bb0320","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1189\/jlb.0507314","article-title":"Differential expression of leukocyte immunoglobulin-like receptors on cord-blood-derived human mast cell progenitors and mature mast cells","volume":"83","author":"Tedla","year":"2008","journal-title":"J. Leukoc. Biol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926013421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926013421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:28:02Z","timestamp":1791466082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926013421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":64,"alternative-id":["S1567576926013421"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117494","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From orphan receptor to versatile regulator: Redefining LILRB3 as a context-dependent immune checkpoint and therapeutic target","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117494","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117494"}}